Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy

In a pilot study of continuous infusion 5-fluorouracil and intermittent bolus doxorubicin and cyclophosphamide in women with breast cancer, four of 24 patients developed symptomatic superior vena cava or innominate vein thrombosis associated with the Hickman line, despite prophylactic treatment with...

Full description

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) 1996, Vol.8 (4), p.247-249
Main Authors: Bissett, D., Kaye, S.B., Baxter, G., Moss, J.
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Biological and medical sciences
Breast Neoplasms - drug therapy
Chemotherapy
Cyclophosphamide - administration & dosage
Doxorubicin - administration & dosage
Female
Fluorouracil - administration & dosage
Gynecology. Andrology. Obstetrics
Hickman line
Humans
Infusions, Intravenous
Mammary gland diseases
Medical sciences
Middle Aged
Pilot Projects
Thrombosis
Thrombosis - chemically induced
Thrombosis - drug therapy
Tumors
Vena Cava, Superior
Warfarin - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a pilot study of continuous infusion 5-fluorouracil and intermittent bolus doxorubicin and cyclophosphamide in women with breast cancer, four of 24 patients developed symptomatic superior vena cava or innominate vein thrombosis associated with the Hickman line, despite prophylactic treatment with very low dose warfarin (1–3 mg/day). In all four patients, local thrombolysis with streptokinase was successful and chemotherapy was continued through the Hickman line under anticoagulant cover, maintaining an international normalized ratio of 2.0–3.0. No patient developed recurrent thrombosis. Prophylactic anticoagulation should be considered in patients receiving continuous infusion chemotherapy through Hickman lines, as they are at risk of proximal vein thrombosis. A randomized study is needed to address the question of the optimum anticoagulant regimen to prevent such thromboses.
ISSN:0936-6555
1433-2981
DOI:10.1016/S0936-6555(05)80661-2